Elevatus Welath Management Invests $243,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Elevatus Welath Management acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 24,650 shares of the company’s stock, valued at approximately $243,000. Other institutional investors also recently bought and sold shares of the […]

Related Keywords

Tina Marriott ,Blake Borgeson ,Quarter For Recursion Pharmaceuticals ,Needham Company ,Nasdaq ,Investment Management ,Vanguard Group Inc ,Recursion Pharmaceuticals Profile ,Sumitomo Mitsui Trust Holdings Inc ,Nikko Asset Management Americas Inc ,Exchange Commission ,Securities Exchange Commission ,Recursion Pharmaceuticals Inc ,News Ratings For Recursion Pharmaceuticals Daily ,Recursion Pharmaceuticals ,Recursion Pharmaceuticals Stock Performance ,Keycorp ,Insider Activity At Recursion Pharmaceuticals ,Elevatus Welath Management ,Free Report ,Asset Management Americas ,Mitsui Trust Holdings ,Vanguard Group ,Get Free Report ,Director Blake Borgeson ,Visit Holdingschannel ,Recursion Pharmaceuticals Daily ,